Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF V600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis
Titel:
Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF V600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis
Auteur:
Blank, Christian U. Larkin, James Arance, Ana M. Hauschild, Axel Queirolo, Paola Del Vecchio, Michele Ascierto, Paolo A. Krajsova, Ivana Schachter, Jacob Neyns, Bart Garbe, Claus Chiarion Sileni, Vanna Mandalà, Mario Gogas, Helen Espinosa, Enrique Hospers, Geke A.P. Miller Jr., Wilson H. Robson, Susan Makrutzki, Martina Antic, Vladan Brown, Michael P.